LAAO and the Watchman FLX; HF Care in Private Equity Hospitals; Long-term Outcomes in TR and Mitral Valve-in-Valve Replacement
In this week’s View, Dr. Eagle looks at the lower risk of major adverse events in patients with left atrial appendage occlusion (LAAO) using the Watchman 2.4 device. He then discusses the impact of heart failure (HF) care in private equity hospitals in the United States. Finally, Dr. Eagle explores the long-term outcomes of patients with tricuspid regurgitation (TR) undergoing mitral valve-in-valve (MViV) replacement.
X Links:
- Kim Eagle, MD, MACC keaglemd
Clinical Topics: Heart Failure and Cardiomyopathies, Vascular Medicine, Acute Heart Failure, Acute Coronary Syndromes, Cardiac Surgery
Keywords: National Cardiovascular Data Registries, LAAO Registry, Ischemic Stroke, Atrial Appendage, Tricuspid Valve Insufficiency, Mitral Valve, STS/ACC TVT Registry, Delivery of Health Care, Hospitals, Private, Cardiac Catheterization, Ownership, Heart Failure, EaglesEyeView
